SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 222 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $34,596 | -24.3% | 1,293,315 | -3.4% | 0.32% | -21.6% |
| Q1 2024 | $45,688 | +19.8% | 1,339,442 | +1.7% | 0.40% | +13.2% |
| Q4 2023 | $38,129 | -1.6% | 1,317,526 | -6.3% | 0.36% | -8.5% |
| Q3 2023 | $38,768 | -7.8% | 1,406,158 | +0.5% | 0.39% | -2.5% |
| Q2 2023 | $42,062 | -18.0% | 1,399,255 | -1.2% | 0.40% | -19.7% |
| Q1 2023 | $51,306 | +2.3% | 1,416,104 | +0.7% | 0.50% | -2.4% |
| Q4 2022 | $50,171 | -99.9% | 1,406,528 | -20.4% | 0.51% | -22.9% |
| Q3 2022 | $59,830,000 | +8.3% | 1,767,489 | -7.5% | 0.66% | +10.7% |
| Q2 2022 | $55,232,000 | -6.5% | 1,909,849 | +4.5% | 0.60% | +13.3% |
| Q1 2022 | $59,052,000 | +10.3% | 1,827,091 | -0.5% | 0.53% | +17.4% |
| Q4 2021 | $53,551,000 | +23.5% | 1,836,466 | +13.0% | 0.45% | +15.8% |
| Q3 2021 | $43,352,000 | -12.9% | 1,625,490 | +0.6% | 0.39% | -10.6% |
| Q2 2021 | $49,760,000 | +20.8% | 1,616,100 | +2.7% | 0.43% | +14.2% |
| Q1 2021 | $41,192,000 | +24.3% | 1,573,411 | +19.4% | 0.38% | +8.9% |
| Q4 2020 | $33,144,000 | +51.5% | 1,317,340 | +25.5% | 0.35% | +21.7% |
| Q3 2020 | $21,880,000 | +16.5% | 1,049,888 | +32.8% | 0.29% | +8.3% |
| Q2 2020 | $18,782,000 | – | 790,801 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $17,478,000 | 3.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,124,405 | $36,341,000 | 3.91% |
| ARMISTICE CAPITAL, LLC | 3,100,000 | $100,192,000 | 1.94% |
| S&T BANK/PA | 316,326 | $10,224,000 | 1.54% |
| Bruce & Co., Inc. | 222,105 | $7,178,000 | 1.47% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 379,875 | $12,278,000 | 1.36% |
| RICE HALL JAMES & ASSOCIATES, LLC | 854,949 | $27,632,000 | 1.10% |
| Soleus Capital Management, L.P. | 251,000 | $8,112,000 | 1.05% |
| Parkman Healthcare Partners LLC | 108,954 | $3,521,000 | 1.03% |
| Aristotle Capital Boston, LLC | 1,258,067 | $40,661,000 | 1.03% |